SCHEMBL7220576

SCHEMBL7220576

COc1cccc(C2C=CC(O)(C#N)C=C2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP2C19 P33261 1/20 0.43
HTR2C P28335 4/20 0.41
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM1A O60341 1/20 0.40
RCOR1 Q9UKL0 1/20 0.40
KDM4E B2RXH2 2/20 0.39
GAA P10253 2/20 0.39
KMT2A Q03164 2/20 0.39
HTR2A P28223 2/20 0.39
HTR2B P41595 2/20 0.39
NPC1 O15118 2/20 0.39
MEN1 O00255 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1532971 0.77 ALDH1A1 (0.33) ALDH1A1HSD17B10KDM1AKDM4EKMT2A
SCHEMBL21359879 0.70 HTR2C (0.51) ALDH1A1HTR2CKDM1ARCOR1KDM4E
SCHEMBL726240 0.70 KDM1A (0.43) ALDH1A1CYP2C19HTR2CKDM1ARCOR1
SCHEMBL2027566 0.69 KDM1A (0.45) ALDH1A1HTR2CKDM1ARCOR1KDM4E
SCHEMBL23676966 0.68 HTR2C (0.61) ALDH1A1HTR2CKDM1ARCOR1KDM4E
SCHEMBL6931634 0.66 MTNR1A (0.37) HTR2CMAPK1KDM1ARCOR1KMT2A
SCHEMBL3023520 0.66 ALDH1A1 (0.64) ALDH1A1MAPK1HSD17B10KDM4EGAA
1,3-Dimethoxybenzene SCHEMBL28356211 0.65 ACHE (0.50) ALDH1A1CYP2C19CES2CES1MAPK1
SCHEMBL24516520 0.65 DDB1 (0.40) ALDH1A1CYP2C19HTR2CKDM1ARCOR1
Methyl Alcohol SCHEMBL8097139 0.65 HTR2C (0.72) HTR2CKDM1ARCOR1HTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620839-B2 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications ABBOTT LABORATORIES 2003-09-16 US disclosed
US-20020137931-A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications ABBVIE INC. 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137931-A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications HRH3, HRH4, HRH1 ALDH1A1 962/4885CYP2C19 1882/4885HTR2C 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.